Loading…
onlineotcmeds.com sold unapproved and misbranded drugs through its website in violation of the Federal Food, Drug, and Cosmetic Act, including opioids, benzodiazepines, and Schedule II stimulants. The FDA found that the company unlawfully introduced these controlled and prescription-class drugs into interstate commerce without proper approval or compliance with labeling requirements. The enforcement action emphasized the public health risks associated with easy internet availability of these drugs, particularly given the ongoing opioid epidemic and the high abuse potential and diversion risk of the products sold.